Which hedge funds own LGND? LIGAND PHARMACEUTICALS INC, Q2 2026 13F holders
24 tracked hedge funds disclosed a position in LGND (LIGAND PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $96.5m in total. The largest holder by portfolio weight is Pavaki Capital Management LLC at 2.0% of its book. 11 opened a new position this quarter: JW Asset Management, LLC, Context Capital Management, LLC, Aristeia Capital, L.L.C., Ares Systematic Credit Ltd. 10 exited: Ishara Investments LP, Quarry LP, Qube Research & Technologies Ltd.
- 24
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 11
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 10
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $44.6m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $22.2m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $96.5m
- Combined value Sum of the holders' reported positions in the security.
- 1.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Ishara Investments LP | 1.7% | $1.6m |
| Quarry LP | 0.04% | $202k |
| Qube Research & Technologies Ltd | 0.01% | $9.5m |
| Walleye Capital LLC | 0.01% | $2.1m |
| Voloridge Investment Management, LLC | 0.01% | $2.5m |
| Freestone Grove Partners LP | 0.0% | $562k |
| Marshall Wace, LLP | 0.0% | $1.5m |
| Arrowstreet Capital, Limited Partnership | 0.0% | $2.9m |
| Citadel Advisors LLC | 0.0% | $1.3m |
| Elequin Capital, LP | 0.0% | $2.6k |
Ownership over time
Who discovered LGND first? Beta
The run: Q4 2012 → Q3 2018, ×13
| Stonepine Capital Management, LLC high conviction | Q2 2020 | – | +1.5 pts |
| Scopia Capital Management LP | Q1 2017 | – | +0.4 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.